News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ShangPharma's Chairman Offers to Take the Company Private



7/6/2012 12:13:50 PM

by Richard Daverman, PhD

July 6, 2012 -- The Chairman/Founder/CEO of ShangPharma Corporation, together with TPG Capital, has made an offer to take the company private at a price of between $8.50 and $9.50 per ADS. Yesterday, ShangPharma closed at $6.88 per ADS. The company, one of China’s largest pre-clinical CROs, made its IPO on the New York Stock Exchange in October 2010 at $15. It is headquartered in Shanghai’s Zhangjiang Hi-Tech Park. More details....

Stock Symbol: (NYSE: SHP)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES